Status:

COMPLETED

Efficacy of Gamification in Enhancing User Engagement

Lead Sponsor:

MapHabit, Inc.

Conditions:

Alzheimer Disease

Dementia

Eligibility:

All Genders

Phase:

NA

Brief Summary

As part of Phase II of the NIH SBIR grant, the study will conduct a randomized controlled clinical trial in which the MapHabit system's gamification is investigated to determine whether the assistive ...

Eligibility Criteria

Inclusion

  • Individual diagnosed with Alzheimer's disease or other related dementia (ADRD) in their mild to moderate stage of impairment
  • Participating caregiver of individual with dementia must be the primary caregiver
  • Proficient in English

Exclusion

  • Individual not diagnosed with ADRD
  • Participating caregiver of individual with dementia is NOT the primary caregiver
  • Not proficient in English

Key Trial Info

Start Date :

September 12 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 28 2023

Estimated Enrollment :

60 Patients enrolled

Trial Details

Trial ID

NCT05422339

Start Date

September 12 2022

End Date

December 28 2023

Last Update

September 29 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MapHabit

Atlanta, Georgia, United States, 30308